CP-154,526
CP-154,526 je potentan i selektivan antagonist Kortikotropin-oslobađajućeg hormonskog receptor 1 koji je razvila kompanija Pfizer .[ 3]
CP-154,526 se ispituje za moguću upotrebu u lečenju alkoholizma .[ 4] [ 5]
Povezano
Literatura
↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.” . Drug Discov Today 15 (23-24): 1052-7. DOI :10.1016/j.drudis.2010.10.003 . PMID 20970519 . edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4 : 217-241. DOI :10.1016/S1574-1400(08)00012-1 .
↑ Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M, Dunaiskis A, Faraci S, Schmidt AW, Seeger T, Seymour P, Tingley FD 3rd, Winston EN, Chen YL, Heym J (September 1996). „CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors” . Proc. Natl. Acad. Sci. U.S.A. 93 (19): 10477–82. DOI :10.1073/pnas.93.19.10477 . PMC 38410 . PMID 8816826 . [mrtav link ]
↑ „Drug Has Potential To Prevent Alcoholics From Relapsing” . Science News . ScienceDaily. 2. 8. 2008.. Pristupljeno 9. 8. 2008 .
↑ Pastor R, McKinnon CS, Scibelli AC, Burkhart-Kasch S, Reed C, Ryabinin AE, Coste SC, Stenzel-Poore MP, Phillips TJ (July 2008). „Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: a urocortin1-independent mechanism” . Proc. Natl. Acad. Sci. U.S.A. 105 (26): 9070–5. DOI :10.1073/pnas.0710181105 . PMC 2449366 . PMID 18591672 .
Spoljašnje veze
Serotoninski modulatori i stimulatori (SMS)
Neselektivni
MAOA -Selektivni
MAOB -Selektivni
Šablon:Neuropeptidni ligandi